CEA -HLA DR14 Normal/Tumor: gut carcinoma(RNA) Peptide Sequence: LWWVNNQSLPVSP Motif Biotech

Filters

Popular peptides

Human body system

Tripeptide Peptide Tag Domain Antagonist peptides Blocker Peptides Antimicrobial peptides Amyloid peptides Inhibitor peptides Targeted Peptide Agonist Peptide

Bioanalytical drug development

RGD Peptides Glycopeptides Dipeptide Cyclodipeptide Substrate Peptide

Nano Peptide

Self-assembling peptides Cell-penetrating Peptides

Beauty peptides

Anti-aging

Anti-inflammatory

Repair

Moisturizing

Whitening

Body care

Drug peptide intermediates and impurities

Neoplasm

Diabetes mellitus

Cardiovascular

Reproductive

Anti-infection

Osteoporosis

Other

Cancer antigenic peptide

Mutation

Differentiation

Overexpressed

Tumor-specific

Catalog peptides

Linker

ADC Linker

Peptide Linker

PDC Linker

RDC linker

PROTAC linker

Reactive Linker

Alkyne Reactive Linker Amine Reactive Linker Azide Reactive Linker Click Reactive Linker Thiol Reactive Linker

Linker Intermediate

Advanced Linker Intermediate

Synthesis of unnatural amino acids and other blocks

Fmoc protects unnatural amino acids

CEA -HLA DR14 (Peptide Sequence: LWWVNNQSLPVSP)

Support

Name CEA -HLA DR14 (Peptide Sequence: LWWVNNQSLPVSP)	Molecular structural formula
Normal/Tumor gut carcinoma(RNA)
HLA DR14(用于人类白细胞抗原 II类)
HLA% 6
Peptide Sequence LWWVNNQSLPVSP
Position 177-189 and 355-367
Lymphocyte Stimulation peptide
NCBI Gene SummaryNCBI This gene encodes a cell surface glycoprotein that represents the founding member of the carcinoembryonic antigen (CEA) family of proteins. The encoded protein is used as a clinical biomarker for gastrointestinal cancers and may promote tumor development through its role as a cell adhesion molecule. Additionally, the encoded protein may regulate differentiation, apoptosis, and cell polarity. This gene is present in a CEA family gene cluster on chromosome 19. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
GeneCards Summary CEACAM5 (CEA Cell Adhesion Molecule 5) is a Protein Coding gene. Diseases associated with CEACAM5 include Lung Non-Small Cell Carcinoma and Bile Duct Cancer. Among its related pathways are Metabolism of proteins and Response to elevated platelet cytosolic Ca2+. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity and GPI anchor binding. An important paralog of this gene is CEACAM1.
UniProtKB SwissProt Summary Cell surface glycoprotein that plays a role in cell adhesion, intracellular signaling and tumor progression (PubMed:2803308, 10910050, 10864933). Mediates homophilic and heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules, such as CEACAM6 (PubMed:2803308). Plays a role as an oncogene by promoting tumor progression; induces resistance to anoikis of colorectal carcinoma cells (PubMed:10910050). ( CEAM5_HUMAN,P06731 ) (Microbial infection) Receptor for E.coli Dr adhesins. Binding of E.coli Dr adhesins leads to dissociation of the homodimer. (CEAM5_HUMAN,P06731)
References [1].Campi G, Crosti M, Consogno G, Facchinetti V, Conti-Fine BM, Longhi R, Casorati G, Dellabona P, Protti MP. CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope. Cancer Res. 2003 Dec 1, 63(23):8481-6. (PMID: 14679013).

* All products on our website are for scientific research and cannot be used in human body

Product details

Data download